5 Stocks Targeted By Short Sellers Recently

4. Unicycive Therapeutics, Inc. (NASDAQ:UNCY)

Change In Short Interest Percentage: 13.45

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) is an American biotechnology company that is headquartered in Los Altos, California. The firm primarily develops treatments for people with kidney problems such as those undergoing dialysis and with kidney injuries. Like Altamira, Unicycive Therapeutics, Inc. (NASDAQ:UNCY)’s short interest percentage has jumped rapidly between February and March 2023, currently sitting at 15.05% from the earlier 1.60%. Total shares short are a whopping 1.39 million up from the previous 180,340.

As of December 2022, one of the 943 hedge funds part of Insider Monkey’s database had invested in Unicycive Therapeutics, Inc. (NASDAQ:UNCY). This lone investor is Wilmot B. Harkey and Daniel Mack’s Nantahala Capital Management which owns 647,416 shares that are worth $349,605.

Follow Unicycive Therapeutics Inc.